Clin2
NCT07531043Possibly a fitNot yet recruiting

Eye drops for redness in adults

Ocular Hyperemia

Part of Eyes & vision clinical trials.

This study tests a new eye drop called FID 123472 to see how well it reduces redness in adults. If you have persistent eye redness and have used redness relief drops before, this trial might help you find a longer-lasting solution.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
230 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be an adult able to give informed consent.
  • You should have used redness relief eye drops in the past 6 months, or be interested in using them, or your doctor thinks you'd benefit.
  • At the start of the study, your eyes must show a certain level of redness (score of 1 or higher on a 5-point scale) in both eyes.
  • You cannot have had eye surgery within 6 months before the study starts.
  • You should not have any other eye conditions that could make the study unsafe for you.
  • Your blood pressure, pulse, and eye pressure must be within normal ranges.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07578363Not yet recruiting· Phase 3
Drop for reducing eye redness

This study tests an experimental eye drop to see if it reduces eye redness better than a placebo (inactive) drop. If you often have red eyes and want a new option, this may be a good fit.

Fort Worth, Texas
NCT07209410Recruiting· Phase 4
Eye drops to reduce redness from glaucoma treatment

This trial tests if adding brimonidine eye drops can reduce eye redness caused by the glaucoma drops you are currently taking. It may help if you have been using netarsudil/latanoprost drops and have noticed redness.

Kansas City, Missouri
NCT07778888Not yet recruiting· Phase 2
Treatment for eye redness in dry eye disease

This study tests a new eye drop that aims to reduce redness in people with dry eye disease. It may help if you have dry eyes and noticeable redness.

NCT04007276Not yet recruiting· Phase 4
Lumify for red eyes in glaucoma patients

This study tests a red-eye relief drop called Lumify (brimonidine tartrate) in people with glaucoma who are already using brimonidine. It looks at whether Lumify changes eye redness, eye pressure, and eyelid position.

New Orleans, Louisiana
NCT07805759Recruiting
Triple action eye drops for allergy symptoms

This trial tests an eye drop called Daydrop Triple Action to see if it helps with eye itching and redness caused by allergies. It might be a good option if you have allergic conjunctivitis and have not used other allergy eye medications recently.

Madrid, Madrid
NCT07625124Not yet recruiting· Phase 2
Eye drop for dry eye disease

This study tests an experimental eye drop for people with dry eye disease. It aims to see if the drops can reduce symptoms and signs of dry eye.

Hear when a new Ocular Hyperemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.